Targeted RNA Sequencing Market Size, Share, Demand, Benefits, Opportunities, Report Studies And Development by 2030
Targeted RNA Sequencing Market Overview:
The Targeted
RNA Sequencing Market has demonstrated noteworthy growth, propelled by
a rising demand for accurate and efficient RNA molecule analysis. Positioned as
an advanced molecular biology technique, targeted RNA sequencing empowers
researchers to concentrate on specific RNA sequences of interest, delivering a
cost-effective and information-rich alternative to conventional methods. Targeted
RNA Sequencing Market was USD 4,554.59 million in 2022 It is projected to reach
USD 8,684.17 million by 2030, indicating a CAGR of 8.5% during the forecast
period.
Market Key Drivers:
The robust
growth of the Targeted
RNA Sequencing Market is underpinned by several key drivers. There is a
discernible uptick in the importance placed on comprehending gene expression
patterns, splicing variants, and RNA modifications. The method's capacity to
provide valuable insights into disease mechanisms, biomarker identification,
and the facilitation of targeted therapeutics development has driven its
widespread adoption in both academic and clinical settings.
Market Segmentation:
Targeted RNA
Sequencing Market can be segmented By Technology (Exome Sequencing, Enrichment
Sequencing, and Amplicon Sequencing), By Application (Biomedical Research,
Plant & Animal Sciences, Drug Discovery, and Others), By End-User (Academic
Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others), By
Region (North America, Europe, Asia-Pacific, Latin America, and Middle East
& Africa)
Top
Key Players in the Targeted RNA Sequencing Market:
·
Roche
Holdings
·
Thermo
Fisher Scientific
·
Illumina
Inc.
·
Agilent
Technologies
·
Oxford
Nanopore Technologies
·
DNASTAR
Inc.
·
QIAGEN
·
BGI
·
Bio-Rad
Laboratories Inc.
·
PierianDx
Regional Analysis:
The foremost share
contribution to market growth was observed in North America, attributed to the
substantial presence of key healthcare research entities and a well-established
healthcare industry. The growth in this region is propelled by escalating investments
in initiatives focusing on new drug development, the expansion of hospital
facilities, and other pertinent factors. Notably, technological advancements
and the heightened demand for innovative drugs are acting as catalysts for
market expansion in North America. This dynamic confluence of factors
underscores the region's pivotal role in shaping and driving the growth
trajectory of the market.
About Us:
Consegic
Business Intelligence Pvt Ltd. is the leading research industry that offers
contextual and data-centric research services to its customers across the
globe. The firm assists its clients to strategize business policies and
accomplish sustainable growth in their respective market domains. The industry
provides consulting services, syndicated research reports, and customized
research reports.
Topnotch
research organizations and institutions to comprehend the regional and global
commercial status use the data produced by Consegic Business Intelligence Pvt
Ltd. Our reports comprise in-depth analytical and statistical analysis on
various industries in foremost countries around the globe.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Comments
Post a Comment